In conclusion, we present novel data of increased serum adipocytokines and pro-inflammatory mediators, despite decreased adipose tissue mass as well as decreased FoxP3 expression in MS patients compared to healthy individuals. The gene discussed is FOXP3; the disease is myeloid sarcoma.